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ABSTRACT 
Economic evaluation is an important tool in health care resource allocation. Interventions are 
typically evaluated through a cost utility analysis (CUA) using the Quality Adjusted Life Year 
(QALY), a metric combining length of life and quality of life (QoL) into a single outcome. The 
quality aspect of the QALY is often provided by a preference-based measure (PBM) that includes 
a way of measuring health, and a preference-based value set. The most commonly used PBMs 
focus on health-related quality of life (HRQoL). However, there is a case for broadening what is 
measured and valued by including other aspects of QoL (such as social care related QoL) 
alongside HRQoL.  
 
This thesis explores how methods for the measurement and valuation of health and QoL can be 
extended to inform the development of broader and more widely applicable instruments. This 
was investigated by first exploring how to incorporate QoL concepts into PBMs, and second by 
testing the further application of Discrete Choice Experiment (DCE) methods to value QoL. Three 
empirical studies were conducted 
 
The first study assessed existing measures of health and QoL using Item Response Theory (IRT), 
and tested two ways in which PBMs could be broadened to incorporate wider QoL concepts. 
The results demonstrated overlap and divergence in what is measured. This informed where 
extra dimensions of QoL could broaden the information collected, and how the information 
collected within existing HRQoL frameworks could be extended. 
 
The second study used DCE to understand respondent preferences for diverse dimensions of 
QoL. The results provided evidence respondents do trade across different concepts of QoL. This 
supports the need for broader measures, and also the use of DCE to value broader outcomes.  
 
The third study focuses on DCE methods, and particularly on the construction of designs for 
DCEs. The results provided detailed information about different design strategies for the 
valuation of QoL outcomes. 
 
The overall findings raise key issues about what should be captured in PBMs, and also provide 
novel information about methods that can be used to inform the assessment, development and 
valuation of future instruments. For example, the results inform how IRT can be used in PBM 
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development. They also suggest how DCE can be used to value diverse QoL concepts. This can 
inform the development and valuation of broader measurement systems of QoL outcomes that 
can increase the scope and enhance the applicability of QALY values used in resource allocation 
decision making. 
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